Bridging radiotherapy

RADIATION2 trials

Sponsors

University College, London, Ruijin Hospital

Conditions

B-NHLCART TherapyDiffuse Large B Cell Lymphoma

Phase 2

Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL

RecruitingNCT06695013

Ruijin HospitalB-NHL, CART Therapy

Start: 2024-11-20End: 2027-03-20Target: 144Updated: 2025-01-24

Unknown Phase

RadiothErapy priMIng for CAR-T

Active, not recruitingNCT04726787

University College, LondonDiffuse Large B Cell Lymphoma

Start: 2022-08-18End: 2025-06-30Updated: 2024-12-09